C-O6LVHuman Longevity Inc.
genomics, imaging, biomarkers
diagnostics
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-O6LV
C-O6LVC-O6LVgenomics, imaging, biomarkers
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Human Longevity Inc. genomics, imaging, biomarkers
Human Longevity offers AI-powered early detection programs combining clinical-grade whole genome sequencing, whole-body MRI, 120+ biomarkers, and physician review. Its programs include Genomics for All, Executive Health, and 100+ Care, with ongoing diagnostics and longitudinal follow-up. The site says the company has served 10,000+ clients, cataloged 400M+ genetic variants, and was co-founded by Dr. J. Craig Venter in 2013.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Human Longevity Inc. — Far from goals · Bottom quartile. Derived deterministically from 5 extracted project(s). Most-advanced status: undisclosed. Band: far. Modifiers: +5 depth (5 programs at undisclosed).…
Source: Deterministic